Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: A randomized trial

Obstetrics and Gynecology

Volumn 94, Issue 6, 1999, Pages 954-961

  Maiman, Mitchell ^a,c   Watts, D Heather ^a   Andersen, Janet ^a,b   Clax, Pamela ^a   Merino, Maria ^a   Kendall, Michelle A ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVAGINAL DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FLUOROURACIL; HIV INFECTIONS; HUMANS; NEOPLASM RECURRENCE, LOCAL; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0032722026     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00407-X     Document Type: Article

References (20)

1. Maiman M., Tarricone N., Viera J., Suarez J., Serur E., Boyce J.G. Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol. 78:1991;84-88.
2. Schrager L.K., Friedland G.H., Maude D., Schreiber K., Adachi A., Pizzuti D.J., et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr. 2:1989;570-575.
3. Feingold A.R., Vermund S., Kelley K.F., Schreiber L.K., Munk G., Friedland G.H. Cervical cytological abnormalities and papillomavirus in women infected with HIV. J Acquir Immune Defic Syndr. 3:1990;896-903.
4. Korn A., Autry M., DeRemer P. Sensitivity of the Papanicolaou smear in human immunodeficiency virus-infected women. Obstet Gynecol. 83:1994;401-404.
5. Wright T.C. Jr, Ellerbrock T.V., Chiasson M.A., Van Devanter N., Sun X.W. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus Prevalence, risk factors and validity of Papanicolaou smears . New York Cervical Disease Study. Obstet Gynecol. 84:1994;591-597.
6. Maiman M., Fruchter R.G., Serur E., Remy J.C., Feuer G., Boyce J.G. Human immunodeficiency virus and cervical neoplasia. Gynecol Oncol. 38:1990;377-382.
7. Fruchter R.G., Maiman M., Sillman F.H., Camilien L., Webber C.A., Kim D.S. Characteristics of cervical intraepithelial neoplasia in women infected with the immunodeficiency virus. Am J Obstet Gynecol. 171:1994;531-537.
8. Conti M., Agarossi A., Parazzini F., Muggiasca M.L., Bochini A., Negri E. HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers. Gynecol Oncol. 49:1993;344-348.
9. Krebs H.B. Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and the vagina. Obstet Gynecol. 68:1986;837-841.
10. Sillman F.H., Sedlis A. Anogenital papillomavirus infection and neoplasia in immunodeficient women An update . Dermatol Clin. 9:1991;353-369.
11. Lindsey J.C., Ryan L.M. Tutorial in biostatistics Methods for interval-censored data . Stat Med. 17:1998;219-238.
12. Maiman M., Fruchter R.G., Serur E., Levine P.L., Arrastia C., Sedlis A. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol. 82:1993;170-174.
13. Petry K.U., Scheffel D., Bode U. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer. 57:1994;836-840.
14. Fruchter R.G., Maiman M., Sedlis A., Bartley L., Camilien L., Arrastia C.D. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 87:1996;338-344.
15. Wright T.C., Koulos J., Schnoll F., Swanback J., Ellerbrock T.V., Chiasson M.A. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus Outcome after loop electrosurgical excision . Gynecol Oncol. 55:1994;253-258.
16. Johnson J., Burnett A., Willet G., Young M.A., Doniger J. High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human deficiency virus-infected women. Obstet Gynecol. 9:1992;321-327.
17. Schafer A., Friedman W., Mielke M., Schwartlander B., Koch M.A. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Obstet Gynecol. 164:1991;593-599.
18. Spinillo A., Tenti P., Zappatore R. Prevalence, diagnosis and treatment of lower genital neoplasia in women with human immunodeficiency virus infection. Eur J Obstet Gynecol Reprod Biol. 43:1992;235-241.
19. Sillman F.H., Sedlis A., Boyce J.G. A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil. Obstet Gynecol Surv. 40:1985;190-220.
20. Krebs H., Helmkamp B.F. Chronic ulcerations following topical therapy with 5-fluorouracil for vaginal human papillomavirus-associated lesions. Obstet Gynecol. 78:1991;205-208.